Simpler stomach bug treatment shows promise in large trial
NCT ID NCT06977841
First seen Mar 22, 2026 · Last updated May 23, 2026 · Updated 12 times
Summary
This study tested whether a new acid-reducing drug called tegoprazan, combined with one or two antibiotics, can safely and effectively treat H. pylori stomach infections. 640 adults who had never been treated for H. pylori took part. The goal was to see if simpler, two-drug regimens work as well as the standard four-drug approach, with fewer side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH-DOSE DUAL THERAPY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Zhongshan Hospital (Xiamen), Fudan University
Xiamen, Fujian, 361015, China
Conditions
Explore the condition pages connected to this study.